Anti-FLCN antibody [EPNCIR147]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal FLCN antibody. Suitable for WB and reacts with Human samples. Cited in 5 publications.
View Alternative Names
BHD, FLCN, Folliculin, BHD skin lesion fibrofolliculoma protein, Birt-Hogg-Dube syndrome protein
- WB
Unknown
Western blot - Anti-FLCN antibody [EPNCIR147] (AB124885)
All lanes:
Western blot - Anti-FLCN antibody [EPNCIR147] (ab124885) at 1/1000 dilution
Lane 1:
293T cell lysate at 10 µg
Lane 2:
NCCIT cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 64 kDa
Observed band size: 70 kDa
false
- WB
Lab
Western blot - Anti-FLCN antibody [EPNCIR147] (AB124885)
Western blot : Anti-FLCN antibody [EPNCIR147] ab124885 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 64 kDa in Wild-type A549 cell lysates with no signal observed at this size in FLCN knockout A549 cell line.
To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 100pc LICOR in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
Lanes 1 - 3:
Western blot - Anti-FLCN antibody [EPNCIR147] (ab124885) at 1/1000 dilution
Lanes 1 - 3:
Western blot - Anti-FLCN antibody [EPNCIR147] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/flcn-antibody-epncir147-bsa-and-azide-free-ab248039'>ab248039</a>) at 1/1000 dilution
Lane 1:
Wild-type A549 at 20 µg
Lane 2:
FLCN knockout A549 at 20 µg
Lane 3:
HEK-293 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 64 kDa
Observed band size: 64 kDa
false
- WB
Lab
Western blot - Anti-FLCN antibody [EPNCIR147] (AB124885)
Lanes 1 - 4 : Merged signal (red and green). Green - ab124885 observed at 64 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.
ab124885 was shown to react with FLCN in wild-type HeLa cells in Western blot with loss of signal observed in FLCN knockout cell line ab265268 (FLCN knockout cell lysate ab257953). Wild-type HeLa and FLCN knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab124885 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-FLCN antibody [EPNCIR147] (ab124885) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
FLCN knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human FLCN knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-flcn-knockout-hela-cell-line-ab265268'>ab265268</a>)
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
HEK-293 cell lysate at 20 µg
Predicted band size: 64 kDa
Observed band size: 64 kDa
false
Related conjugates and formulations (1)
-
Anti-FLCN antibody [EPNCIR147] - BSA and Azide free
Reactivity data
Product details
This antibody was developed as part of a collaboration between the National Cancer Institute's Center for Cancer Research and the lab of Marston Linehan. View antibodies from NCI Center for Cancer Research Collaboration.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FLCN plays a role in energy and nutrient sensing within cells. It forms part of a complex with FNIP1 and FNIP2 proteins which helps regulate cellular growth and metabolism. This complex acts as a hub for integrating various signaling pathways influencing how cells respond to changing metabolic states.
Pathways
Research connects FLCN to the mTOR signaling pathway and AMP-activated protein kinase (AMPK) pathway which are critical for cellular metabolism and energy homeostasis. The interaction between FLCN and the mTOR pathway facilitates control over cell growth and proliferation by sensing cellular energy levels. Moreover FLCN associates with pathways that include proteins like TSC1 and TSC2 which also contribute to the regulation of these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Nature 620:200-208 PubMed37407815
2023
Applications
Unspecified application
Species
Unspecified reactive species
PLoS biology 20:e3001594 PubMed35358174
2022
Applications
Unspecified application
Species
Unspecified reactive species
Human molecular genetics 28:3270-3281 PubMed31272105
2019
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 5: PubMed30843872
2019
Applications
Unspecified application
Species
Unspecified reactive species
Genes & development 30:2551-2564 PubMed27913603
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com